237 related articles for article (PubMed ID: 29860290)
1. Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
Toor J; Alsallaq R; Truscott JE; Turner HC; Werkman M; Gurarie D; King CH; Anderson RM
Clin Infect Dis; 2018 Jun; 66(suppl_4):S245-S252. PubMed ID: 29860290
[TBL] [Abstract][Full Text] [Related]
2. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
Kura K; Hardwick RJ; Truscott JE; Toor J; Hollingsworth TD; Anderson RM
Parasit Vectors; 2020 Nov; 13(1):554. PubMed ID: 33203467
[TBL] [Abstract][Full Text] [Related]
3. Improving public health control of schistosomiasis with a modified WHO strategy: a model-based comparison study.
Li EY; Gurarie D; Lo NC; Zhu X; King CH
Lancet Glob Health; 2019 Oct; 7(10):e1414-e1422. PubMed ID: 31537371
[TBL] [Abstract][Full Text] [Related]
4. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis.
NTD Modelling Consortium Schistosomiasis Group
Gates Open Res; 2019; 3():1517. PubMed ID: 31701091
[TBL] [Abstract][Full Text] [Related]
5. What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?
Anderson RM; Turner HC; Farrell SH; Yang J; Truscott JE
Parasit Vectors; 2015 Oct; 8():553. PubMed ID: 26489831
[TBL] [Abstract][Full Text] [Related]
6. Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment.
Ayabina D; Kura K; Toor J; Graham M; Anderson RM; Hollingsworth TD
Clin Infect Dis; 2021 Jun; 72(Suppl 3):S140-S145. PubMed ID: 33909064
[TBL] [Abstract][Full Text] [Related]
7. FioSchisto's expert perspective on implementing WHO guidelines for schistosomiasis control and transmission elimination in Brazil.
Menezes CA; Montresor LC; Jangola STG; de Mattos AC; Domingues ALC; Júnior AM; Silva CCM; Barbosa CS; de Mendonça CLF; Massara CL; Fonseca CT; de Oliveira EJ; Gomes ECS; da Silva EF; Bezerra FSM; Silva-Jr FP; de Siqueira IC; Silva JRME; Heller L; Farias LP; Beck LCNH; Santos MCS; Lima MG; Mourão MM; Enk MJ; Fernandez MA; Katz N; Carvalho ODS; Parreiras PM; Neves RH; Gava SG; de Oliveira SA; Thiengo SC; Favre TC; Graeff-Teixeira C; Pieri OS; Caldeira RL; da Silva-Pereira RA; Rocha RS; Oliveira RR
Front Immunol; 2023; 14():1268998. PubMed ID: 38143743
[TBL] [Abstract][Full Text] [Related]
8. Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination.
Kura K; Truscott JE; Toor J; Anderson RM
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007349. PubMed ID: 31166956
[TBL] [Abstract][Full Text] [Related]
9. Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration.
Kura K; Collyer BS; Toor J; Truscott JE; Hollingsworth TD; Keeling MJ; Anderson RM
Vaccine; 2020 Jun; 38(28):4379-4386. PubMed ID: 32418795
[TBL] [Abstract][Full Text] [Related]
10. Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities.
Anderson RM; Turner HC; Farrell SH; Truscott JE
Adv Parasitol; 2016; 94():199-246. PubMed ID: 27756455
[TBL] [Abstract][Full Text] [Related]
11. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections.
Farrell SH; Coffeng LE; Truscott JE; Werkman M; Toor J; de Vlas SJ; Anderson RM
Clin Infect Dis; 2018 Jun; 66(suppl_4):S253-S259. PubMed ID: 29860285
[TBL] [Abstract][Full Text] [Related]
13. Tailoring Water, Sanitation, and Hygiene (WASH) Targets for Soil-Transmitted Helminthiasis and Schistosomiasis Control.
Campbell SJ; Biritwum NK; Woods G; Velleman Y; Fleming F; Stothard JR
Trends Parasitol; 2018 Jan; 34(1):53-63. PubMed ID: 29055522
[TBL] [Abstract][Full Text] [Related]
14. The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.
Toor J; Turner HC; Truscott JE; Werkman M; Phillips AE; Alsallaq R; Medley GF; King CH; Anderson RM
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006717. PubMed ID: 30296257
[TBL] [Abstract][Full Text] [Related]
15. [Effect of mid- and long-term schistosomiasis control plan and discussion of consolidation strategy in marshland endemic regions].
Shen XH; Sun LP; Li YF; Wang L; Chen XP; Wang HS; Dai JR
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Oct; 27(5):457-62. PubMed ID: 26930927
[TBL] [Abstract][Full Text] [Related]
16. What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
Kura K; Hardwick RJ; Truscott JE; Anderson RM
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009946. PubMed ID: 34851952
[TBL] [Abstract][Full Text] [Related]
17. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.
Kura K; Ayabina D; Toor J; Hollingsworth TD; Anderson RM
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):236-244. PubMed ID: 33515038
[TBL] [Abstract][Full Text] [Related]
18. Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies.
Kittur N; Campbell CH; Binder S; Shen Y; Wiegand RE; Mwanga JR; Kinung'hi SM; Musuva RM; Odiere MR; Matendechero SH; Knopp S; Colley DG
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):24-29. PubMed ID: 32400365
[TBL] [Abstract][Full Text] [Related]
19. Time to set the agenda for schistosomiasis elimination.
Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
[TBL] [Abstract][Full Text] [Related]
20. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison.
Collyer BS; Turner HC; Hollingsworth TD; Keeling MJ
Parasit Vectors; 2019 Oct; 12(1):499. PubMed ID: 31647019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
